Skip to main content
Premium Trial:

Request an Annual Quote

Rubicon Licenses DNA Amplification Tech to Sigma-Aldrich

NEW YORK, Oct. 5 (GenomeWeb News) - Rubicon Genomics has granted Sigma-Aldrich an exclusive, worldwide license to GenomePlex, Rubicon's whole-genome amplification technology, the companies said today.

 

Under the terms of the agreement, Sigma-Aldrich will have exclusive world-wide rights to produce and sell GenomePlex kits to the research market. Rubicon, based in Ann Arbor, Mich., will retain all rights to the technology for its core market - molecular diagnostics - as well as for service, the companies said.

 

Financial details of the agreement were not disclosed.

 

Rubicon said that GenomePlex amplifies total human DNA at the sub-nanogram level by using random, non-enzymatic fragmentation of genomic DNA followed by the addition of specific adaptor sequences to both ends, forming an in vitro molecular library that can be amplified with conventional techniques.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.